Losartan + Sunitinib in Treatment of Osteosarcoma

NCT03900793 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Osteosarcoma

Interventions

DRUG: Losartan
DRUG: Sunitinib

Sponsor

University of Colorado, Denver

Collaborators

[object Object]
[object Object]
[object Object]